Liraglutide studies: 1,219 papers with results
Page 15 of 25
- Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort Analysis.
Zimner Rapuch S · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
Observational study · 6 results
- Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden: a national cohort study.
Taipale H · The lancet. Psychiatry · 2026
Observational study · 10 results
- Comparison between liraglutide and dulaglutide on the incidence or progression of eye and kidney complications.
Katamine A · Journal of diabetes investigation · 2026
Observational study · 4 results
- Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.
Taipale H · Acta psychiatrica Scandinavica · 2026
Observational study · 7 results
- Comparative Efficacy of Tirzepatide, Liraglutide, and Semaglutide in Reduction of Risk of Major Adverse Cardiovascular Events in Patients with Obstructive Sleep Apnea and Type 2 Diabetes: Real-World Evidence.
Henney AE · Annals of the American Thoracic Society · 2025
Observational study · 11 results
- Weight loss in people with type 1 diabetes over 12 months: Real-world data comparing tirzepatide, semaglutide and liraglutide.
Al Ozairi E · Diabetes, obesity & metabolism · 2026
Observational study · 17 results
- Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes.
Mirabelli M · Journal of clinical medicine · 2021
Observational study · 10 results
- Appetite Suppression by GLP-1 Receptor Agonists: Role of Delayed Gastric Emptying.
Friedman MI · Obesity (Silver Spring, Md.) · 2026
Observational study · 8 results
- Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
Mirabelli M · Journal of the Endocrine Society · 2021
Observational study · 10 results
- Retrospective study comparing healthcare costs and utilization between commercially insured patients with type 2 diabetes mellitus who are newly initiating exenatide once weekly or liraglutide in the United States.
Johnston SS · Journal of medical economics · 2015
Observational study · 8 results
- Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial.
Sklepinski SM · Diabetes research and clinical practice · 2025
Observational study · 14 results
- Target Trial Emulations of GLP-1 and Dual GLP-1/GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 Diabetes.
Henney AE · Liver international : official journal of the International Association for the Study of the Liver · 2025
Observational study · 9 results
- Liraglutide Versus Exenatide Once Weekly: Persistence, Adherence, and Early Discontinuation.
Yu M · Clinical therapeutics · 2016
Observational study · 9 results
- Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10).
Brown-Frandsen K · Diabetes, obesity & metabolism · 2019
Observational study · 3 results
- Relative efficacy of GLP-1 and GLP-1/GIP receptor agonists in the prevention of alcohol-use disorders using a target trial emulation approach.
Henney AE · Diabetes, obesity & metabolism · 2026
Observational study · 6 results
- Glycemic Control and Weight Outcomes for Exenatide Once Weekly Versus Liraglutide in Patients with Type 2 Diabetes: A 1-Year Retrospective Cohort Analysis.
McAdam-Marx C · Clinical therapeutics · 2016
Observational study · 6 results
- Real-world comparison of treatment patterns and effectiveness of albiglutide and liraglutide.
Buysman EK · Journal of comparative effectiveness research · 2018
Observational study · 5 results
- Retrospective real-world adherence in patients with type 2 diabetes initiating once-daily liraglutide 1.8 mg or twice-daily exenatide 10 μg.
Malmenäs M · Clinical therapeutics · 2013
Observational study · 4 results
- The influence of pharmaceutically induced weight changes on estimates of renal function: A patient-level pooled analysis of seven randomised controlled trials of glucose lowering medication.
von Scholten BJ · Journal of diabetes and its complications · 2015
Observational study · 5 results
- Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12-month follow-up in a real-world setting in the United States.
Mody R · Diabetes, obesity & metabolism · 2019
Observational study · 4 results
- A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies.
Wei W · Diabetes, obesity & metabolism · 2017
Observational study · 4 results
- Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis.
Chang KC · Cardiovascular diabetology · 2020
Observational study · 10 results
- Effectiveness and Persistence of Liraglutide Treatment Among Patients with Type 2 Diabetes Treated in Primary Care and Specialist Settings: A Subgroup Analysis from the EVIDENCE Study, a Prospective, 2-Year Follow-up, Observational, Post-Marketing Study.
Martinez L · Advances in therapy · 2017
Observational study · 10 results
- Comprehensive analysis of real-world data on liraglutide treatment in patients with obesity: a multicenter national study.
Hepşen S · European journal of medical research · 2025
Observational study · 8 results
- The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12 months.
Guerci B · Diabetes, obesity & metabolism · 2022
Observational study · 8 results
- Effectiveness of liraglutide 3 mg for the treatment of obesity in a real-world setting without intensive lifestyle intervention.
Park JH · International journal of obesity (2005) · 2021
Observational study · 16 results
- Real-world cost-effectiveness: lower cost of treating patients to glycemic goal with liraglutide versus exenatide.
DeKoven M · Advances in therapy · 2014
Observational study · 3 results
- Predictors of response to liraglutide in Japanese type 2 diabetes.
Toyoda M · Diabetes research and clinical practice · 2014
Observational study · 2 results
- Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort.
Mirani M · Pharmacological research · 2018
Observational study · 11 results
- Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland.
Haase CL · Obesity facts · 2021
Observational study · 12 results
- Glucagon-Like Peptide 1 (GLP-1) Receptor Variants and Glycemic Response to Liraglutide: A Pharmacogenetics Study in Iranian People with Type 2 Diabetes Mellitus.
Eghbali M · Advances in therapy · 2024
Observational study · 3 results
- Incidence of adhesions in patients using liraglutide before laparoscopic sleeve gastrectomy.
Hakim M · Surgical endoscopy · 2022
Observational study · 1 result
- Comparative evaluation of liraglutide plus metformin combination therapy versus metformin monotherapy in patients with type 2 diabetes mellitus: A retrospective clinical study.
Mai T · Medicine · 2026
Observational study · 8 results
- Long-term effectiveness and safety of liraglutide in clinical practice.
Ponzani P · Minerva endocrinologica · 2013
Observational study · 9 results
- Liraglutide in a real-world setting: Joint modeling of metabolic response, prediction of efficacy, and cardiovascular risk.
Alonso-Troncoso I · Endocrinologia, diabetes y nutricion · 2019
Observational study · 7 results
- Retinopathy risk factors in patients with type 2 diabetes on liraglutide.
Mahzari MM · Medicine · 2024
Observational study · 10 results
- Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study.
Tanaka K · Scientific reports · 2022
Observational study · 2 results
- Clinical effectiveness of liraglutide on weight loss in South Koreans: First real-world retrospective data on Saxenda in Asia.
Park JS · Medicine · 2021
Observational study · 7 results
- Independent glucose and weight-reducing effects of Liraglutide in a real-world population of type 2 diabetic outpatients.
Fadini GP · Acta diabetologica · 2013
Observational study · 8 results
- An association between liraglutide treatment and reduction in excessive daytime sleepiness in obese subjects with type 2 diabetes.
Gomez-Peralta F · BMC endocrine disorders · 2015
Observational study · 11 results
- A Study on Weight Loss Cause as per the Side Effect of Liraglutide.
Yu J · Cardiovascular therapeutics · 2022
Observational study · 15 results
- Liraglutide in the management of obesity: real world data (Portugal).
Tavares Bello C · Minerva endocrinology · 2025
Observational study · 8 results
- Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 Diabetes.
Iwamoto N · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2018
Observational study · 10 results
- The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study.
Thong KY · Diabetic medicine : a journal of the British Diabetic Association · 2014
Observational study · 4 results
- Effects of 3-month liraglutide treatment on oxidative stress and inflammation in type 2 diabetes patients with different urinary albumin-to-creatinine ratio categories.
Chen S · Medicine · 2024
Observational study · 13 results
- Mental health changes after 4 months of weight loss treatment with the glucagon-like peptide-1 analogue liraglutide 3.0 mg.
Kuckuck S · Diabetes, obesity & metabolism · 2026
Observational study · 8 results
- Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis.
Guirguis A · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2024
Observational study · 16 results
- One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study.
Zavattaro M · Endocrine · 2015
Observational study · 10 results
- The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone.
Ohki T · TheScientificWorldJournal · 2012
Observational study · 6 results
- Effectiveness of Liraglutide in Patients With Obesity Who Are Early Non-Responders to Lifestyle Intervention: A Real-World Study.
Gilardini L · Journal of obesity · 2026
Observational study · 9 results